1. Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC; 2014.
2. Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016;27(1):1–25.
3. Landrum LM, Zuna RE, Walker JL. Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer. In: DiSaia PJ, Creasman WT, editors. Clinical gynecologic oncology. Philadelphia: Mosby Elsevier; 2007. p. 121–8.
4. Classification and diagnosis of endometrial hyperplasia [Internet].
Uptodate.com
. 2017.
https://www.uptodate.com/contents/classification-and-diagnosis-of-endometrial-hyperplasia?search=reed%20sd,urban%20r.%20r.%20classification%20and%20diagnosis%20of%20endometrial%20hyperplasia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
. Accessed 19 Dec 2017.
5. Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, Voigt LF, Weiss NS. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009;200(6):678.e1–6.